Keyphrases
Systemic Sclerosis
100%
Fibroblasts
100%
Fibrosis
100%
Monocytes
100%
Multi-organ
100%
Poly(lactic-co-glycolic acid) Nanoparticles
100%
Macrophage Receptor with Collagenous Structure
100%
Macrophages
40%
Lung Fibrosis
40%
Mouse Model
20%
Lesional Skin
20%
Poly(lactic-co-glycolic acid)
20%
Skin Fibrosis
20%
Fibrotic Response
20%
Lung
20%
Multisystem
20%
FDA-approved Drugs
20%
Orphan Disease
20%
Novel Nanoparticles
20%
Clinical Course
20%
Surface Expression
20%
Isolated Cells
20%
Effector Cells
20%
Bleomycin
20%
Lung Inflammation
20%
Chronic Inflammation
20%
Skin Inflammation
20%
High Mortality Rate
20%
Cells in Culture
20%
Biodegradable Polymers
20%
Inflammatory Monocytes
20%
Scavenger Receptor
20%
Carboxylate
20%
Short-term Treatment
20%
Activated Myofibroblasts
20%
Preclinical Disease Models
20%
Chronic Fibrosis
20%
Pharmacology, Toxicology and Pharmaceutical Science
Nanoparticle
100%
Polyglactin
100%
Systemic Sclerosis
100%
Receptor
100%
Fibrosis
100%
Lung Fibrosis
40%
Mouse Model
20%
Scavenger Receptor
20%
Skin Fibrosis
20%
Bleomycin
20%
Dermatitis
20%
Mortality Rate
20%
Disease Course
20%
Chronic Inflammation
20%
Disease Model
20%
Diseases
20%
Immunology and Microbiology
Macrophage
100%
Glycolic Acid
100%
Fibroblast
100%
Systemic Scleroderma
71%
Effector Cell
14%
Pulmonary Inflammation
14%
Mouse Model
14%
Mortality Rate
14%
Scavenger Receptor
14%
Myofibroblast
14%